JP2012516890A5 - - Google Patents

Download PDF

Info

Publication number
JP2012516890A5
JP2012516890A5 JP2011549157A JP2011549157A JP2012516890A5 JP 2012516890 A5 JP2012516890 A5 JP 2012516890A5 JP 2011549157 A JP2011549157 A JP 2011549157A JP 2011549157 A JP2011549157 A JP 2011549157A JP 2012516890 A5 JP2012516890 A5 JP 2012516890A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
ring
phenyl
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011549157A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012516890A (ja
JP5659166B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/000307 external-priority patent/WO2010090737A1/en
Publication of JP2012516890A publication Critical patent/JP2012516890A/ja
Publication of JP2012516890A5 publication Critical patent/JP2012516890A5/ja
Application granted granted Critical
Publication of JP5659166B2 publication Critical patent/JP5659166B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011549157A 2009-02-05 2010-02-04 ピリダジノン化合物 Active JP5659166B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20220709P 2009-02-05 2009-02-05
US61/202,207 2009-02-05
US21392709P 2009-07-30 2009-07-30
US61/213,927 2009-07-30
PCT/US2010/000307 WO2010090737A1 (en) 2009-02-05 2010-02-04 Pyridazinone compounds

Publications (3)

Publication Number Publication Date
JP2012516890A JP2012516890A (ja) 2012-07-26
JP2012516890A5 true JP2012516890A5 (enExample) 2013-03-14
JP5659166B2 JP5659166B2 (ja) 2015-01-28

Family

ID=42398214

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011549157A Active JP5659166B2 (ja) 2009-02-05 2010-02-04 ピリダジノン化合物

Country Status (37)

Country Link
US (7) US8354411B2 (enExample)
EP (2) EP2393360B1 (enExample)
JP (1) JP5659166B2 (enExample)
KR (1) KR101730665B1 (enExample)
CN (1) CN102365020B (enExample)
AR (1) AR075238A1 (enExample)
AU (1) AU2010211050B2 (enExample)
BR (1) BRPI1008498B8 (enExample)
CA (1) CA2751565C (enExample)
CO (1) CO6410258A2 (enExample)
CR (1) CR20110440A (enExample)
DK (1) DK2393360T3 (enExample)
DO (1) DOP2011000254A (enExample)
EA (1) EA020690B1 (enExample)
EC (1) ECSP11011305A (enExample)
ES (1) ES2561181T3 (enExample)
GE (1) GEP20146004B (enExample)
HR (1) HRP20160065T1 (enExample)
HU (1) HUE027478T2 (enExample)
IL (1) IL214137A (enExample)
JO (1) JO3114B1 (enExample)
MA (1) MA33072B1 (enExample)
ME (1) ME02337B (enExample)
MX (1) MX2011008305A (enExample)
MY (1) MY170610A (enExample)
NZ (1) NZ594851A (enExample)
PE (1) PE20110991A1 (enExample)
PL (1) PL2393360T3 (enExample)
RS (1) RS54504B1 (enExample)
SG (1) SG173175A1 (enExample)
SI (1) SI2393360T1 (enExample)
SM (1) SMT201600008B (enExample)
TN (1) TN2011000362A1 (enExample)
TW (1) TWI457333B (enExample)
UY (1) UY32417A (enExample)
WO (1) WO2010090737A1 (enExample)
ZA (1) ZA201106074B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009054791A1 (en) * 2007-10-26 2009-04-30 Astrazeneca Ab Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5
JP5627574B2 (ja) * 2008-06-03 2014-11-19 インターミューン, インコーポレイテッド 炎症性および線維性疾患を治療するための化合物および方法
EP2393360B1 (en) * 2009-02-05 2015-11-04 Takeda Pharmaceutical Company Limited Pyridazinone compounds
TWI546302B (zh) 2010-06-24 2016-08-21 武田藥品工業股份有限公司 稠合雜環化合物
US20130116231A1 (en) * 2010-07-12 2013-05-09 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors
EP2602255B1 (en) * 2010-08-04 2017-04-26 Takeda Pharmaceutical Company Limited Fused heterocyclic ring compound
JP5800813B2 (ja) 2010-08-04 2015-10-28 武田薬品工業株式会社 複素環化合物
WO2012018909A1 (en) 2010-08-04 2012-02-09 Takeda Pharmaceutical Company Limited Fused heterocyclic compounds
WO2012020780A1 (ja) 2010-08-10 2012-02-16 武田薬品工業株式会社 複素環化合物およびその用途
JP2013234123A (ja) * 2010-09-03 2013-11-21 Taisho Pharmaceutical Co Ltd 3−ピラゾリル−2−ピリドン誘導体
KR20140009372A (ko) 2011-02-18 2014-01-22 알러간, 인코포레이티드 포스포다이에스테라제 10(pde10a)의 억제제로서의 치환된 6,7-다이알콕시-3-아이소퀴놀리놀 유도체
EP2687529B1 (en) 2011-03-16 2016-07-13 Takeda Pharmaceutical Company Limited Condensed heterocyclic compound
US10314594B2 (en) 2012-12-14 2019-06-11 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US10307167B2 (en) 2012-12-14 2019-06-04 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US10813630B2 (en) 2011-08-09 2020-10-27 Corquest Medical, Inc. Closure system for atrial wall
CN103889974B (zh) * 2011-08-22 2017-10-03 武田药品工业株式会社 放射性标记的化合物和它们在哺乳动物中作为磷酸二酯酶(pde10a)的定量成像的放射示踪剂的用途
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
UA111861C2 (uk) 2011-11-15 2016-06-24 Такеда Фармасьютікал Компані Лімітед Ароматична гетероциклічна сполука дигідрокси
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US20140142689A1 (en) 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction
EA201591540A1 (ru) * 2013-02-21 2016-01-29 Такеда Фармасьютикал Компани Лимитед Способ получения производных пиридазинона
US9464076B2 (en) 2013-03-15 2016-10-11 Daiichi Sankyo Company, Limited Benzothiophene derivative
WO2015006689A1 (en) 2013-07-12 2015-01-15 University Of South Alabama Treatment and diagnosis of cancer and precancerous conditions using pde10a inhibitors and methods to measure pde10a expression
CN105722831B (zh) * 2013-09-12 2019-08-06 艾丽奥斯生物制药有限公司 哒嗪酮化合物及其用途
AU2014318832B2 (en) 2013-09-12 2018-11-29 Janssen Biopharma, Inc. Aza-pyridone compounds and uses thereof
US9566443B2 (en) 2013-11-26 2017-02-14 Corquest Medical, Inc. System for treating heart valve malfunction including mitral regurgitation
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
ES2544869B2 (es) * 2014-03-04 2016-01-18 Universidade De Vigo Derivados de piridazin-3(2H)-ona inhibidores selectivos de la isoforma B de la monoaminooxidasa
US10231929B2 (en) 2014-03-18 2019-03-19 Takeda Pharmaceutical Company Limited Solid dispersion
CN106459042B (zh) 2014-04-02 2019-06-28 英特穆恩公司 抗纤维化吡啶酮类
US10842626B2 (en) 2014-12-09 2020-11-24 Didier De Canniere Intracardiac device to correct mitral regurgitation
MX383931B (es) 2015-03-11 2025-03-14 Janssen Biopharma Inc Compuestos de aza-piridona y usos de estos.
WO2016191935A1 (en) * 2015-05-29 2016-12-08 Merck Sharp & Dohme Corp. 6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors
BR112018011817A2 (pt) 2015-12-22 2018-12-04 Jiangsu Hengrui Medicine Co derivado de benzopiperidina, método de preparação do mesmo, e uso médico do mesmo
US10736894B2 (en) 2018-02-15 2020-08-11 Ovid Therapeutics Inc. Methods of treating developmental syndromes with PDE10A inhibitors
CN108498868B (zh) * 2018-04-03 2020-09-15 北京大学口腔医学院 具有细胞外基质电学拓扑特征的带电复合膜及其制备方法
CN110407806B (zh) * 2018-04-28 2021-08-17 深圳微芯生物科技股份有限公司 甲酰胺类化合物、其制备方法及其应用
WO2019241787A1 (en) * 2018-06-15 2019-12-19 The Regents Of The University Of Colorado A Body Corporate Novel cyclic gmp-amp synthase (cgas) inhibitors and their method of use
WO2020065583A1 (en) * 2018-09-28 2020-04-02 Takeda Pharmaceutical Company Limited Balipodect for treating or preventing autism spectrum disorders
MX2019008440A (es) 2019-07-15 2021-01-18 Dva Farma Mexicana S A De C V Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion.
EP3805206A1 (en) * 2019-10-08 2021-04-14 Novaled GmbH Compound and an organic semiconducting layer, an organic electronic device, a display device and a lighting device comprising the same
GB202002926D0 (en) 2020-02-28 2020-04-15 Benevolentai Tech Limited Compositions and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0011693A1 (de) * 1978-10-03 1980-06-11 Ciba-Geigy Ag Neue N-(trifluormethansulfonylaminophenyl)-substituierte N-Heterocyclen, ihre Herstellung, sie enthaltende Mittel und ihre Verwendung zur Beeinflussung des Pflanzenwachstums
FR2648135B1 (fr) 1989-06-07 1991-09-27 Pf Medicament Derives de phenyl-1-dihydro-1,4 amino-3 oxo-4 pyridazines, leur preparation et leur application en therapeutique
GB9506382D0 (en) 1995-03-29 1995-05-17 Boots Co Plc Pharmaceutical compositions
AU756275B2 (en) 1998-08-14 2003-01-09 Nihon Nohyaku Co., Ltd. Pyridazinone derivatives
US20070060606A1 (en) * 1999-10-07 2007-03-15 Robertson Harold A Compounds and methods for modulating phosphodiesterase 10A
GB0013383D0 (en) 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
DK1318997T3 (da) 2000-09-15 2006-09-25 Vertex Pharma Pyrazolforbindelser der er nyttige som proteinkinase-inhibitorer
US7005432B2 (en) 2002-05-16 2006-02-28 Hoffman-La Roche Inc. Substituted imidazol-pyridazine derivatives
EP1755611A1 (en) 2004-06-07 2007-02-28 Pfizer Products Inc. Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions
RU2346996C2 (ru) 2004-06-29 2009-02-20 ЮРОПИЭН НИКЕЛЬ ПиЭлСи Усовершенствованное выщелачивание основных металлов
ATE472543T1 (de) 2005-01-07 2010-07-15 Pfizer Prod Inc Heteroaromatische chinolinverbindungen und deren verwendung als pde10-inhibitoren
JP4890439B2 (ja) * 2005-03-07 2012-03-07 杏林製薬株式会社 ピラゾロピリジン−4−イルピリダジノン誘導体とその付加塩及びそれらを有効成分とするpde阻害剤
CA2654394A1 (en) 2006-06-26 2008-01-03 Pfizer Products Inc. Tricyclic heteroaryl compounds as pde10 inhibitors
TW200801513A (en) 2006-06-29 2008-01-01 Fermiscan Australia Pty Ltd Improved process
US20080090834A1 (en) 2006-07-06 2008-04-17 Pfizer Inc Selective azole pde10a inhibitor compounds
US8642660B2 (en) 2007-12-21 2014-02-04 The University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2010000020A1 (en) 2008-06-30 2010-01-07 Cathrx Ltd A catheter
TW201030001A (en) 2008-11-14 2010-08-16 Amgen Inc Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
TWI396689B (zh) 2008-11-14 2013-05-21 Amgen Inc 作為磷酸二酯酶10抑制劑之吡衍生物
SG171954A1 (en) * 2008-12-04 2011-07-28 Hoffmann La Roche Pyridazinone derivatives
EP2393360B1 (en) 2009-02-05 2015-11-04 Takeda Pharmaceutical Company Limited Pyridazinone compounds
US9187455B2 (en) 2009-02-23 2015-11-17 Hoffmann-La Roche Inc. Substituted pyridazines as PDE10A inhibitors
US8415381B2 (en) 2009-07-30 2013-04-09 Novartis Ag Heteroaryl compounds and their uses
EP2602255B1 (en) * 2010-08-04 2017-04-26 Takeda Pharmaceutical Company Limited Fused heterocyclic ring compound
WO2012020780A1 (ja) * 2010-08-10 2012-02-16 武田薬品工業株式会社 複素環化合物およびその用途

Similar Documents

Publication Publication Date Title
JP2012516890A5 (enExample)
AU2016256728B2 (en) Thiadiazole analogs thereof and methods for treating smn-deficiency-related-conditions
CA2958490C (en) Pyrazolo[1,5-a]pyrazin-4-yl derivatives
RU2757457C2 (ru) Пирролопиримидины в качестве потенциаторов мвтр
CA2836851C (en) Pyrazolo[3,4-d]pyrimidine compounds and their use as pde2 inhibitors and/or cyp3a4 inhibitors
JP4101852B2 (ja) シンナミド化合物
US9150588B2 (en) Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors
EA012211B1 (ru) Гетероароматические соединения хинолинов и их применение в качестве ингибиторов pde10
HUE031755T2 (hu) Pirazol vegyületek sigma receptor inhibitorokként
JP2009500327A (ja) アミノ−5−(5員)ヘテロアリールイミダゾロン化合物およびβ−セレクターゼ調節のためのその使用
EA021359B1 (ru) N-((6-аминопиридин-3-ил)метил)гетероарилкарбоксамиды в качестве ингибиторов калликреина в плазме
CN103781768B (zh) Pde10调节剂
AU2009257795A1 (en) Pyrazole derivatives useful as inhibitors of FAAH
JPWO2015012400A1 (ja) グリシントランスポーター阻害物質
KR101842382B1 (ko) 모폴린-피리딘 유도체
JP4827821B2 (ja) シンナミド化合物
WO2007037513A9 (ja) アリール置換含窒素複素環化合物
TW200944522A (en) 3-indazolyl-4-pyridylisothiazoles